P2RY12 and acute coronary syndrome: Gragnano et al. [4] showed that clopidogrel, rather than potent P2Y12 inhibitors, is frequently used of as part of dual antiplatelet therapy in real-world high-bleeding risk patients presenting with acute coronary syndromes.